X

Trial Profile

A Placebo-controlled, Double-blind, Randomized Trial of a Single Intra-articular Delivery of SB-061 for the Treatment of Symptomatic Osteoarthritis of the Knee

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 25 Apr 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SB 061 (Primary)
Indications Osteoarthritis
Focus Adverse reactions; Therapeutic Use
Acronyms MODIFY2
Sponsors Symic OA

Most Recent Events

07 Feb 2018 According to a Symic Bio media release, additional data will be presented at an upcoming medical conference.
07 Feb 2018 Top line results are published in a Symic Bio media release.
07 Feb 2018 Status changed from active, no longer recruiting to completed, according to a Symic Bio media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com